Literature DB >> 21609350

Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes.

Lili Chen1, Zhen Yang, Bin Lu, Qin Li, Zi Ye, Min He, Ying Huang, Xuanchun Wang, Zhaoyun Zhang, Jie Wen, Chao Liu, Shen Qu, Renming Hu.   

Abstract

OBJECTIVE: To assess the relationship between serum chemokine CXC ligand 5 (CXCL5) and intima-media thickness (IMT) of the common carotid artery, a marker of preclinical atherosclerosis. DESIGN, PATIENTS AND MEASUREMENTS: We measured the IMT (mean of three segments of both carotid arteries by ultrasonography), serum CXCL5, fasting plasma glucose, serum insulin, serum urea, serum uric acid, HbA1c, serum CRP, adiponectin and lipid profile of 730 Chinese type 2 diabetic participants older than 30 years in a cross-sectional community-based study performed in downtown Shanghai.
RESULTS: Serum CXCL5 correlated with carotid IMT (r = 0·112, P = 0·019) after adjustment for age, gender, serum CRP and HbA1c. Multivariate linear regression analysis demonstrated that age (P = 2·30 × 10(-7) ), gender (P = 2·70 × 10(-2) ), systolic blood pressure (P = 9·26 × 10(-3) ), serum CRP (P = 2·12 × 10(-2) ), low-density lipoprotein cholesterol (P = 2·40 × 10(-2) ), CXCL5 (P = 5·27 × 10(-3) ) and high-density lipoprotein cholesterol (P = 3·80 × 10(-3) ) were independently associated with carotid IMT.
CONCLUSIONS: Serum CXCL5 is an important determinant of carotid artery IMT in patients with type 2 diabetes. The correlation is independent of inflammation and glucose control.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21609350     DOI: 10.1111/j.1365-2265.2011.04119.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  Importance of receptor-targeted systems in the battle against atherosclerosis.

Authors:  Elisabet Rosas; Igor Sobenin; Alexander Orekhov; Elazer R Edelman; Mercedes Balcells
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

2.  Increased serum CXCL1 and CXCL5 are linked to obesity, hyperglycemia, and impaired islet function.

Authors:  Craig S Nunemaker; H Grace Chung; Gretchen M Verrilli; Kathryn L Corbin; Aditi Upadhye; Poonam R Sharma
Journal:  J Endocrinol       Date:  2014-06-13       Impact factor: 4.286

3.  Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals.

Authors:  Li Qin; Zhen Yang; Hongxia Gu; Shuai Lu; Qun Shi; Yin Xing; Xiaoyong Li; Rui Li; Guang Ning; Qing Su
Journal:  BMC Cardiovasc Disord       Date:  2014-02-25       Impact factor: 2.298

4.  Platelets direct monocyte differentiation into epithelioid-like multinucleated giant foam cells with suppressive capacity upon mycobacterial stimulation.

Authors:  Yonghong Feng; Anca Dorhoi; Hans-Joachim Mollenkopf; Hongyun Yin; Zhengwei Dong; Ling Mao; Jun Zhou; Aixiao Bi; Stephan Weber; Jeroen Maertzdorf; Gang Chen; Yang Chen; Stefan H E Kaufmann
Journal:  J Infect Dis       Date:  2014-07-01       Impact factor: 5.226

5.  ENA-78 Is a Novel Predictor of Wound Healing in Patients with Diabetic Foot Ulcers.

Authors:  Ju-Yi Li; Zhong-Jing Wang; Ai-Ping Deng; Yu-Ming Li
Journal:  J Diabetes Res       Date:  2019-01-15       Impact factor: 4.011

6.  Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes.

Authors:  Li Sheng; Wenjie Cao; Bingbing Cha; Zhaoping Chen; Fang Wang; Jun Liu
Journal:  Cardiovasc Diabetol       Date:  2013-01-23       Impact factor: 9.951

7.  CXCL5 polymorphisms are associated with variable blood pressure in cardiovascular disease-free adults.

Authors:  Amber L Beitelshees; Christina L Aquilante; Hooman Allayee; Taimour Y Langaee; Gregory J Welder; Richard S Schofield; Issam Zineh
Journal:  Hum Genomics       Date:  2012-08-02       Impact factor: 4.639

8.  Sex-specific regulation of chemokine Cxcl5/6 controls neutrophil recruitment and tissue injury in acute inflammatory states.

Authors:  Shimona Madalli; Martina Beyrau; James Whiteford; Johan Duchene; Inderpal Singh Nandhra; Nimesh S A Patel; Madhur P Motwani; Derek W Gilroy; Christoph Thiemermann; Sussan Nourshargh; Ramona S Scotland
Journal:  Biol Sex Differ       Date:  2015-11-26       Impact factor: 5.027

9.  Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease.

Authors:  Saranya Ravi; Robert N Schuck; Eleanor Hilliard; Craig R Lee; Xuming Dai; Kaitlin Lenhart; Monte S Willis; Brian C Jensen; George A Stouffer; Cam Patterson; Jonathan C Schisler
Journal:  Am J Pathol       Date:  2017-11-16       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.